TRML — TOURMALINE BIO INC

Ownership history in US BANCORP \DE\  ·  5 quarters on record

This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in TOURMALINE BIO INC (TRML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 144 -88 -37.9% 0.00% $7K —
2025 Q2 ADDED 232 +153 +193.7% 0.00% $4K —
2025 Q1 REDUCED 79 -20 -20.2% 0.00% $1K —
2024 Q4 ADDED 99 +79 +395.0% 0.00% $2K —
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding TRML

As of 2025 Q3 — sorted by position size

Qiming U.S. Ventures Management, LLC 3Y 63.76% PFIZER INC 13.91% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 13.27% QVT Financial LP 3Y 7Y 7.27% Chicago Capital Management, LLC 3Y 7Y 4.81% TCG Crossover Management, LLC 3Y 3.09% Vivo Capital, LLC 3Y 7Y 2.28% HARVEST MANAGEMENT LLC 3Y 7Y 2.07% Versor Investments LP 3Y 7Y 1.91% NEXPOINT ASSET MANAGEMENT, L.P. 3Y 1.89%
← Back to US BANCORP \DE\ Holdings